1 | another | 8,949 |
2 | om-er | 29 |
3 | non-immunogenic | 10 |
4 | norkar | 9 |
5 | non-select | 7 |
6 | crikvenica | 5 |
7 | irrisafe | 5 |
8 | rastelli | 5 |
9 | 1,767 | 4 |
10 | 12-beam | 4 |
11 | anti-crotalic | 4 |
12 | bayirli | 4 |
13 | phosphoramidate | 4 |
14 | plfad3 | 4 |
15 | 15-member | 3 |
16 | a.hydrophila | 3 |
17 | artemether-lumefantrinein | 3 |
18 | block-trained | 3 |
19 | cgi-s. | 3 |
20 | intrapregnancy | 3 |
21 | ipi/aa-ipi | 3 |
22 | n-oleoyldopamine | 3 |
23 | non-mosaic | 3 |
24 | oxfu+cetuximab | 3 |
25 | per-site | 3 |
26 | supplement-based | 3 |
27 | time.the | 3 |
28 | 0.62x100 | 2 |
29 | 46-49 | 2 |
30 | 4α-phorbol | 2 |
31 | acidotolerant | 2 |
32 | anti-diarrheic | 2 |
33 | copd.the | 2 |
34 | diltiazem-based | 2 |
35 | eco-safety | 2 |
36 | enchanted | 2 |
37 | gonal-f. | 2 |
38 | hpv-31/45 | 2 |
39 | laboratory-acquired | 2 |
40 | low-prioritized | 2 |
41 | no-fracture | 2 |
42 | nonadoption | 2 |
43 | post-neutral | 2 |
44 | post-prosthetic | 2 |
45 | postprosthetic | 2 |
46 | timi-11b | 2 |
47 | xp-e | 2 |
48 | zootherapies | 2 |
49 | 'wish-fulfilling | 1 |
50 | 0.29+/-0.02 | 1 |
51 | 122,406 | 1 |
52 | 217+/-11 | 1 |
53 | 33,480-52,840 | 1 |
54 | 8000-fold | 1 |
55 | a-2-year-old | 1 |
56 | a/eq/richmond/1/07 | 1 |
57 | a14-month-old | 1 |
58 | active/non | 1 |
59 | acyclovir-controlled | 1 |
60 | biomarker-assessed | 1 |
61 | clarithromycin.the | 1 |
62 | dimethoxytrityle | 1 |
63 | ebv- | 1 |
64 | fair/poor-quality | 1 |
65 | functional-experiential | 1 |
66 | hbp-guided | 1 |
67 | indapamide.in | 1 |
68 | ironic-absurd | 1 |
69 | lac-hydrin | 1 |
70 | levofloxain | 1 |
71 | levonorgestreland | 1 |
72 | lte-treated | 1 |
73 | maprotiline-treated | 1 |
74 | mononitrates | 1 |
75 | month.every | 1 |
76 | nine-years-old | 1 |
77 | non-ramp | 1 |
78 | non-self-relevant | 1 |
79 | nonperfect | 1 |
80 | nonrandomized-controlled | 1 |
81 | pip/taz-amc-treated | 1 |
82 | reference/citation | 1 |
83 | slowly.we | 1 |
84 | tocoloytic | 1 |
85 | un-conceived | 1 |
86 | woman.one | 1 |
87 | year.one | 1 |
1 | 'wish-fulfilling | 1 |
2 | 0.29+/-0.02 | 1 |
3 | 0.62x100 | 2 |
4 | 1,767 | 4 |
5 | 12-beam | 4 |
6 | 122,406 | 1 |
7 | 15-member | 3 |
8 | 217+/-11 | 1 |
9 | 33,480-52,840 | 1 |
10 | 46-49 | 2 |
11 | 4α-phorbol | 2 |
12 | 8000-fold | 1 |
13 | a-2-year-old | 1 |
14 | a.hydrophila | 3 |
15 | a/eq/richmond/1/07 | 1 |
16 | a14-month-old | 1 |
17 | acidotolerant | 2 |
18 | active/non | 1 |
19 | acyclovir-controlled | 1 |
20 | another | 8,949 |
21 | anti-crotalic | 4 |
22 | anti-diarrheic | 2 |
23 | artemether-lumefantrinein | 3 |
24 | bayirli | 4 |
25 | biomarker-assessed | 1 |
26 | block-trained | 3 |
27 | cgi-s. | 3 |
28 | clarithromycin.the | 1 |
29 | copd.the | 2 |
30 | crikvenica | 5 |
31 | diltiazem-based | 2 |
32 | dimethoxytrityle | 1 |
33 | ebv- | 1 |
34 | eco-safety | 2 |
35 | enchanted | 2 |
36 | fair/poor-quality | 1 |
37 | functional-experiential | 1 |
38 | gonal-f. | 2 |
39 | hbp-guided | 1 |
40 | hpv-31/45 | 2 |
41 | indapamide.in | 1 |
42 | intrapregnancy | 3 |
43 | ipi/aa-ipi | 3 |
44 | ironic-absurd | 1 |
45 | irrisafe | 5 |
46 | laboratory-acquired | 2 |
47 | lac-hydrin | 1 |
48 | levofloxain | 1 |
49 | levonorgestreland | 1 |
50 | low-prioritized | 2 |
51 | lte-treated | 1 |
52 | maprotiline-treated | 1 |
53 | mononitrates | 1 |
54 | month.every | 1 |
55 | n-oleoyldopamine | 3 |
56 | nine-years-old | 1 |
57 | no-fracture | 2 |
58 | non-immunogenic | 10 |
59 | non-mosaic | 3 |
60 | non-ramp | 1 |
61 | non-select | 7 |
62 | non-self-relevant | 1 |
63 | nonadoption | 2 |
64 | nonperfect | 1 |
65 | nonrandomized-controlled | 1 |
66 | norkar | 9 |
67 | om-er | 29 |
68 | oxfu+cetuximab | 3 |
69 | per-site | 3 |
70 | phosphoramidate | 4 |
71 | pip/taz-amc-treated | 1 |
72 | plfad3 | 4 |
73 | post-neutral | 2 |
74 | post-prosthetic | 2 |
75 | postprosthetic | 2 |
76 | rastelli | 5 |
77 | reference/citation | 1 |
78 | slowly.we | 1 |
79 | supplement-based | 3 |
80 | time.the | 3 |
81 | timi-11b | 2 |
82 | tocoloytic | 1 |
83 | un-conceived | 1 |
84 | woman.one | 1 |
85 | xp-e | 2 |
86 | year.one | 1 |
87 | zootherapies | 2 |
1 | ebv- | 1 |
2 | gonal-f. | 2 |
3 | cgi-s. | 3 |
4 | 0.62x100 | 2 |
5 | 33,480-52,840 | 1 |
6 | 217+/-11 | 1 |
7 | 0.29+/-0.02 | 1 |
8 | plfad3 | 4 |
9 | hpv-31/45 | 2 |
10 | 122,406 | 1 |
11 | a/eq/richmond/1/07 | 1 |
12 | 1,767 | 4 |
13 | 46-49 | 2 |
14 | crikvenica | 5 |
15 | a.hydrophila | 3 |
16 | timi-11b | 2 |
17 | oxfu+cetuximab | 3 |
18 | non-mosaic | 3 |
19 | anti-diarrheic | 2 |
20 | anti-crotalic | 4 |
21 | non-immunogenic | 10 |
22 | post-prosthetic | 2 |
23 | postprosthetic | 2 |
24 | tocoloytic | 1 |
25 | hbp-guided | 1 |
26 | nonrandomized-controlled | 1 |
27 | acyclovir-controlled | 1 |
28 | block-trained | 3 |
29 | laboratory-acquired | 2 |
30 | diltiazem-based | 2 |
31 | supplement-based | 3 |
32 | biomarker-assessed | 1 |
33 | pip/taz-amc-treated | 1 |
34 | maprotiline-treated | 1 |
35 | lte-treated | 1 |
36 | enchanted | 2 |
37 | un-conceived | 1 |
38 | low-prioritized | 2 |
39 | a14-month-old | 1 |
40 | a-2-year-old | 1 |
41 | nine-years-old | 1 |
42 | 8000-fold | 1 |
43 | levonorgestreland | 1 |
44 | ironic-absurd | 1 |
45 | xp-e | 2 |
46 | irrisafe | 5 |
47 | copd.the | 2 |
48 | time.the | 3 |
49 | clarithromycin.the | 1 |
50 | dimethoxytrityle | 1 |
51 | n-oleoyldopamine | 3 |
52 | woman.one | 1 |
53 | year.one | 1 |
54 | no-fracture | 2 |
55 | phosphoramidate | 4 |
56 | per-site | 3 |
57 | slowly.we | 1 |
58 | 'wish-fulfilling | 1 |
59 | rastelli | 5 |
60 | bayirli | 4 |
61 | ipi/aa-ipi | 3 |
62 | functional-experiential | 1 |
63 | post-neutral | 2 |
64 | 4α-phorbol | 2 |
65 | 12-beam | 4 |
66 | indapamide.in | 1 |
67 | levofloxain | 1 |
68 | artemether-lumefantrinein | 3 |
69 | lac-hydrin | 1 |
70 | reference/citation | 1 |
71 | nonadoption | 2 |
72 | active/non | 1 |
73 | non-ramp | 1 |
74 | norkar | 9 |
75 | om-er | 29 |
76 | 15-member | 3 |
77 | another | 8,949 |
78 | zootherapies | 2 |
79 | mononitrates | 1 |
80 | nonperfect | 1 |
81 | non-select | 7 |
82 | acidotolerant | 2 |
83 | non-self-relevant | 1 |
84 | intrapregnancy | 3 |
85 | month.every | 1 |
86 | eco-safety | 2 |
87 | fair/poor-quality | 1 |